RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

Go back to RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.64 -0.01 (1.54%)
Previous Close $0.65    52 Week High $16.54 
Open $0.66    52 Week Low $8.10 
Day High $0.68    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 255,062